Intrapatient competition of VEXAS syndrome and CML clones

Blood Adv. 2023 Nov 28;7(22):6815-6818. doi: 10.1182/bloodadvances.2023010814.

Authors

Nadia Djerbi¹, Kathrin Zimmermann¹, Marco Roncador^{1

2}, Mike Oliver Becker³, Markus G Manz¹, Stefan Balabanov¹

Affiliations

¹ Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
² Department of Biosystems Science and Engineering, Eidgenössische technische Hochschule Zurich, Basel, Switzerland.
³ Department of Rheumatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

No abstract available

Publication types

Case Reports

MeSH terms

Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / complications
Myelodysplastic Syndromes* / complications
Skin Diseases, Genetic* / complications

Supplementary concepts

VEXAS syndrome